Long-term follow-up of patients treated with VVI pacing and sequential pacing with special reference to VA retrograde conduction. 1988

A Ebagosti, and M Gueunoun, and A Saadjian, and E Dolla, and M Gabriel, and S Levy, and J Torresani
Service de Cardiologie, Chemin des Bourrely, Marseille, France.

The aim of this prospective study is comparing long-term prognosis in patients implanted with a VVI pacemaker (group A) with those implanted with a sequential pacing device, AAI or DDD, (group B). Both groups of 45 patients each, were comparable as regards to age, sex, pacing indications, underlying heart disease, and technical conditions of implantation and were followed-up over 55 months. Atrial arrhythmias (A.A.) incidence was higher in group A: 24.4% than group B: 8.8% (P less than 0.05). Arterial embolisms (A.E.) occurred in group A patients only. Worsening or occurrence of exercise limitation was more frequent in group A: 35.6% as compared to group B: 13.3% (P less than 0.05) and deaths related to these complications, occurred in seven cases in group A versus four cases in group B. In group A, all patients who experienced a worsening or occurrence of an A.A. or an A.E., had a ventriculoatrial conduction (VAC). No statistical difference was observed in worsening or occurrence of exercise limitation between patients with VAC and those without VAC: nine (42.8%) and seven (29.2%) but they respectively experienced at least one complication in 16 cases (76.2%) and seven cases (29.2%) (P less than 0.01). In conclusion, long-term prognosis in patients implanted with VVI pacing as compared to patients implanted with sequential pacing is poorer. The presence of VAC in patients treated with permanent VVI pacing is a major factor for complications and deaths related to A.E. and cardiac failure. Thus VVI pacing should be avoided in patients with VAC.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010138 Pacemaker, Artificial A device designed to stimulate, by electric impulses, contraction of the heart muscles. It may be temporary (external) or permanent (internal or internal-external). Cardiac Pacemaker, Artificial,Artificial Cardiac Pacemaker,Artificial Cardiac Pacemakers,Artificial Pacemaker,Artificial Pacemakers,Cardiac Pacemakers, Artificial,Pacemaker, Artificial Cardiac,Pacemakers, Artificial,Pacemakers, Artificial Cardiac
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002304 Cardiac Pacing, Artificial Regulation of the rate of contraction of the heart muscles by an artificial pacemaker. Pacing, Cardiac, Artificial,Artificial Cardiac Pacing,Artificial Cardiac Pacings,Cardiac Pacings, Artificial,Pacing, Artificial Cardiac,Pacings, Artificial Cardiac
D004617 Embolism Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream. Embolus,Embolisms
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

A Ebagosti, and M Gueunoun, and A Saadjian, and E Dolla, and M Gabriel, and S Levy, and J Torresani
January 1997, Acta cardiologica,
A Ebagosti, and M Gueunoun, and A Saadjian, and E Dolla, and M Gabriel, and S Levy, and J Torresani
January 1990, Wiadomosci lekarskie (Warsaw, Poland : 1960),
A Ebagosti, and M Gueunoun, and A Saadjian, and E Dolla, and M Gabriel, and S Levy, and J Torresani
January 1972, Scandinavian journal of urology and nephrology,
A Ebagosti, and M Gueunoun, and A Saadjian, and E Dolla, and M Gabriel, and S Levy, and J Torresani
December 1999, Circulation,
A Ebagosti, and M Gueunoun, and A Saadjian, and E Dolla, and M Gabriel, and S Levy, and J Torresani
August 1970, Vnitrni lekarstvi,
A Ebagosti, and M Gueunoun, and A Saadjian, and E Dolla, and M Gabriel, and S Levy, and J Torresani
April 2005, The American journal of cardiology,
A Ebagosti, and M Gueunoun, and A Saadjian, and E Dolla, and M Gabriel, and S Levy, and J Torresani
November 2001, Heart (British Cardiac Society),
A Ebagosti, and M Gueunoun, and A Saadjian, and E Dolla, and M Gabriel, and S Levy, and J Torresani
October 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
A Ebagosti, and M Gueunoun, and A Saadjian, and E Dolla, and M Gabriel, and S Levy, and J Torresani
July 1985, Neurologia medico-chirurgica,
A Ebagosti, and M Gueunoun, and A Saadjian, and E Dolla, and M Gabriel, and S Levy, and J Torresani
June 2006, Revue neurologique,
Copied contents to your clipboard!